Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Gleiter

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Pharmacology|April 1, 1994
Maprotiline metabolism appears to co-segregate with the genetically-determined CYP2D6 polymorphic hydroxylation of debrisoquineL Firkusny, C H Gleiter
Journal of Clinical Pharmacology|September 2, 1998
Assessment of drug accumulation in the evaluation of pharmacokinetic dataI Meineke, C H Gleiter
Der Internist|October 22, 2003
[Phytotherapeutic medicines. A possible source of drug interactions]K Mörike, C H Gleiter
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Adenosinergic psychopharmaceuticals: just an extra cup of coffee?J Deckert, C H Gleiter
Der Internist|October 11, 2014
[Herbal medicines: when to use or not to use?]K Mörike, C H Gleiter
Deutsche Medizinische Wochenschrift (1946)|April 11, 1997
[Fluoxetine]C H Gleiter, H P Volz
Drug Safety|July 1, 1994
Bioinequivalence and drug toxicity. How great is the problem and what can be done?C H Gleiter, U Gundert-Remy
Fortschritte Der Medizin|April 20, 1991
[Clinical drug trials. Part 2. Legal regulations, (EG-) guidelines, ethics commission]C H Gleiter, P R Bieck
Advances in Alcohol & Substance Abuse|January 1, 1988
Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitorC H Gleiter, D J Nutt
Psychopharmacology|January 1, 1988
Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranesC H Gleiter, D J Nutt
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|April 1, 1994
Maprotiline metabolism appears to co-segregate with the genetically-determined CYP2D6 polymorphic hydroxylation of debrisoquineL Firkusny, C H Gleiter
Journal of Clinical Pharmacology|September 2, 1998
Assessment of drug accumulation in the evaluation of pharmacokinetic dataI Meineke, C H Gleiter
Der Internist|October 22, 2003
[Phytotherapeutic medicines. A possible source of drug interactions]K Mörike, C H Gleiter
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Adenosinergic psychopharmaceuticals: just an extra cup of coffee?J Deckert, C H Gleiter
Der Internist|October 11, 2014
[Herbal medicines: when to use or not to use?]K Mörike, C H Gleiter
Deutsche Medizinische Wochenschrift (1946)|April 11, 1997
[Fluoxetine]C H Gleiter, H P Volz
Drug Safety|July 1, 1994
Bioinequivalence and drug toxicity. How great is the problem and what can be done?C H Gleiter, U Gundert-Remy
Fortschritte Der Medizin|April 20, 1991
[Clinical drug trials. Part 2. Legal regulations, (EG-) guidelines, ethics commission]C H Gleiter, P R Bieck
Advances in Alcohol & Substance Abuse|January 1, 1988
Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitorC H Gleiter, D J Nutt
Psychopharmacology|January 1, 1988
Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranesC H Gleiter, D J Nutt
Pageof 11